These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 25738575)
1. Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics. Shastri MD; Stewart N; Eapen M; Peterson GM; Zaidi ST; Gueven N; Sohal SS; Patel RP PLoS One; 2015; 10(3):e0118798. PubMed ID: 25738575 [TBL] [Abstract][Full Text] [Related]
2. Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals. Shastri MD; Stewart N; Horne J; Zaidi ST; Sohal SS; Peterson GM; Korner H; Gueven N; Patel RP PLoS One; 2015; 10(6):e0128803. PubMed ID: 26046354 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy. Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530 [TBL] [Abstract][Full Text] [Related]
5. Ion exchange chromatographic separation and isolation of oligosaccharides of intact low-molecular-weight heparin for the determination of their anticoagulant and anti-inflammatory properties. Shastri MD; Johns C; Hutchinson JP; Khandagale M; Patel RP Anal Bioanal Chem; 2013 Jul; 405(18):6043-52. PubMed ID: 23712644 [TBL] [Abstract][Full Text] [Related]
6. Identification of pro- and anti-proliferative oligosaccharides of heparins. Lean QY; Patel RP; Stewart N; Sohal SS; Gueven N Integr Biol (Camb); 2014 Jan; 6(1):90-9. PubMed ID: 24310794 [TBL] [Abstract][Full Text] [Related]
7. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications. Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680 [TBL] [Abstract][Full Text] [Related]
8. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Oddera S; Silvestri M; Sacco O; Lantero S; Morelli MC; Rossi GA Ann Allergy Asthma Immunol; 1995 Jul; 75(1):33-40. PubMed ID: 7621058 [TBL] [Abstract][Full Text] [Related]
10. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521 [TBL] [Abstract][Full Text] [Related]
11. In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin. Shastri MD; Stewart N; Horne J; Peterson GM; Gueven N; Sohal SS; Patel RP PLoS One; 2015; 10(5):e0126763. PubMed ID: 25961885 [TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin. Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302 [TBL] [Abstract][Full Text] [Related]